Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.25 USD | -1.75% | -8.20% | -29.25% |
May. 15 | Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA | CI |
May. 15 | Lumos Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- LUMO Stock
- Revisions Lumos Pharma, Inc.